Recent Headlines
GenScript Will Launch Services with GANP® Technology for World Wide Market Excluding Japan
GenScript Corporation signed a worldwide (excluding Japan) non-exclusive license agreement with TransGenic Inc. through which GenScript Corporation is authorized to use GANP® mice from TransGenic Inc. to produce high-affinity antibodies to scientists. - March 25, 2011 - GenScript USA Inc.
Science of Cardiac Function Assessment Using Pressure Volume Loops Web Seminar
Online Educational Web Seminar to Explain the Pressure and Volume Changes During the Cardiac Cycle. Scisense Inc. hosts Dr. Richard Klabunde, author of “Cardiovascular Physiology Concepts,” to explain the significance of pressure and volume changes during the cardiac cycle on cardiovascular function, covering relationships such as ESPVR, PRSW, and EDPVR. - March 23, 2011 - Scisense Systems Inc.
GenScript Launches New Website in Germany
GenScript USA Inc. has launched a new website at www.genscript.de in Germany to offer easier access for local German searchers. - March 16, 2011 - GenScript USA Inc.
BioAtla and Charles River Partner for Integrated Biological Service for Preclinical Development
BioAtla and Charles River have recently partnered to create an integrated biological service for antibodies and other protein therapeutics designed to accelerate drug development for customers from the earliest stages of discovery all the way through IND. - March 09, 2011 - BioAtla
AnaSpec Introduces Cherry™Express T7 Protein Expression Kits
AnaSpec, Eurogentec Group is pleased to introduce CherryTMExpress T7 Protein Express Kits from Eurogentec. The Cherry™Express kit allows direct visualization through the whole process of T7 protein expression, production and purification without the need for any special requirements or... - February 24, 2011 - AnaSpec, EGT Group
AnaSpec Showcases Premium Quality of Fluorescent Nucleic Acid Probes
AnaSpec is pleased to showcase a variety of premium quality stains, including cell-impermeant and cell-permeant nucleic acid stains. The detection of nucleic acids is important for many life science research tasks, such as sequencing, cDNA synthesis and cloning, RNA transcription and transfection. - February 24, 2011 - AnaSpec, EGT Group
OSO BioPharmaceuticals to Sponsor Forum on Subcutaneous Biologic Drug Delivery Trends and Best Practices at DCAT Week
The 2011 DCAT Week Biologics Forum will present regulatory and pharmaceutical industry leaders discussing current requirements, trends and best practices for subcutaneous biologic drug delivery systems. - February 24, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
AnaSpec Signs Distribution Agreement with In Vitr
AnaSpec, Eurogentec Group and In Vitro have announced a non-exclusive distributor agreement that will allow In Vitro and its European branches to distribute AnaSpec’s catalog and custom products for Peptides, Fluorescent Dyes, Antibodies, Assay Kits, and Amino Acids throughout Europe. In... - February 18, 2011 - AnaSpec, EGT Group
AnaSpec Offers α & β-Synuclein Recombinant Proteins
AnaSpec, Eurogentec Group, is pleased to offer two recombinant proteins for use in Neurodegenerative Disease Research, α-synuclein (SNCA) and β-synuclein (SNCB). Both α-synuclein and β-synuclein are expressed and purified from E. coli. α-Synuclein is a 140-amino acid... - February 18, 2011 - AnaSpec, EGT Group
AnaSpec Introduces SensoLyte® SIRT2 Assay Kits Fluorimetric
Expanding on their offerings of long wavelength, highly sensitive SIRT assays, AnaSpec, Eurogentec Group, is pleased to release 2 assay kits for SIRT2, the SensoLyte® 520 FRET SIRT2 Assay Kit and the SensoLyte® Green SIRT2 Assay Kit. The substrate found in the SensoLyte® 520 FRET SIRT2... - February 16, 2011 - AnaSpec, EGT Group
Apogen for Anti-Virus, New Dietary Supplement by FEBICO
FEBICO invested almost 10 years of R&D in the self cultivation of their organic spirulina FEM101 to extract the purest water soluble Apogen microalgae protein. In a research collaborated with the Graduate Institute of Biomedical Sciences of Chang Gung University in 1999, they found that the... - February 08, 2011 - Far East Bio-Tech Co., Ltd
Oncolytics Biotech® Inc. Announces 2-Arm, Randomized Phase II Pancreatic Cancer Study
Oncolytics Biotech Inc. (“Oncolytics”) announced that the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute (NCI), which is part of the National Institutes of Health, has agreed to sponsor a 2-Arm randomized Phase II study of... - February 04, 2011 - Oncolytics Biotech
Susan Schniepp, VP of Quality at OSO BioPharmaceuticals, Elected to PDA Board of Directors
Susan Schniepp, vice president of quality at OSO BioPharmaceuticals Manufacturing, LLC, has been elected to the board of directors at the Parenteral Drug Association (PDA). Schniepp has enjoyed a long and productive relationship with the PDA. In addition to serving on numerous committees and being... - January 28, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
AnaSpec Introduces Industry’s First Fluorimetric Assay - SensoLyte® Cathepsin G Kits
AnaSpec, Eurogentec Group, is pleased to announce the release of the industry's first fluorimetric kits for Cathepsin G, the SensoLyte® 520 Cathepsin G Assay Kit and SensoLyte® Rh110 Cathepsin G Assay Kit. These long-wavelength, homogeneous assays are ideal for the screening of enzyme... - January 22, 2011 - AnaSpec, EGT Group
AnaSpec Offers PEGylated Amino Acids
AnaSpec, Eurogentec Group, is pleased to highlight their wide collection of Fmoc- and Boc-protected PEGylated amino acids for PEGylated peptides synthesis. PEGylation has become a well-accepted method for the delivery of biopharmaceuticals-especially peptide and protein drugs.1-4 Simple... - January 22, 2011 - AnaSpec, EGT Group
OSO BioPharmaceuticals Taps Craig Mastenbaum to Lead West Coast Business Development
OSO BioPharmaceuticals Manufacturing, LLC, has named Craig Mastenbaum director of new business development for its West Coast market. Mastenbaum brings to OsoBio more than 30 years of leadership experience in clinical and contract liquid, lyophilized, ampule and syringe product manufacturing. Most... - January 21, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
GenScript Corporation Has Installed the First BiacoreTM T200 Biosensor in the World
GenScript Corporation and GE Healthcare Life Sciences China together held an opening ceremony on Dec 22nd 2010 in Nanjing China, to celebrate the successful installation of the first unit of BiacoreTM T200 instrument in the world. To an audience of primarily research scientists from both big... - January 19, 2011 - GenScript USA Inc.
Oncolytics Biotech® Inc. Announces Opening of Enrollment in U.S. Phase I Colorectal Cancer Study
The principal investigator of the new colon cancer trial using Reolysin is Dr. Sanjay Goel of the Montefiore Medical Center at The Albert Einstein College of Medicine in New York. - January 13, 2011 - Oncolytics Biotech
AnaSpec Introduces Industry’s First FRET-Based - SensoLyte® Green Elastase Assay Kits
AnaSpec, Eurogentec Group is pleased to introduce the SensoLyte® Green Elastase Assay Kit - the first FRET-based Elastase activity assay kit in the industry. This kit employs a natural substrate, elastin that is labeled with the 5-FAM fluorophore and the QXL™ 520 quencher. Proteolytic... - December 30, 2010 - AnaSpec, EGT Group
AnaSpec Expands Anti-GFP Collection – mAb & Chicken Polyclonal Antibodies
AnaSpec is pleased to expand their GFP antibodies offerings. The new GFP antibodies include two monoclonals raised in mouse and a third, a polyclonal raised in chicken. Purified green-fluorescent protein (GFP) was used as antigen. Antibody reactivity was confirmed by ELISA and specificity was... - December 30, 2010 - AnaSpec, EGT Group
AnaSpec Offers Double-Dye Oligo Synthesis Service
AnaSpec, Eurogentec Group is pleased to highlight our Double-Dye Oligo Synthesis Service. With over 20 years expertise of oligonucleotide synthesis, and Eurogentec production facilities in San Diego, California and Liege, Belgium, AnaSpec now offers the largest number of fluorescent reporters and... - December 22, 2010 - AnaSpec, EGT Group
AnaSpec Expands HCV NS3/4A Protease Selection
AnaSpec, Eurogentec Group is pleased to announce the expansion of their NS3/4A protease selection to include proteases from genotypes 1a, 1b, 2a, 3a and 4d. These recombinant HCV NS3/4A proteases are highly active and can be used with the SensoLyte® 490, 520, or 620 HCV Protease Assay Kits for... - December 22, 2010 - AnaSpec, EGT Group
Anti-5-Methylcytidine Antibody from AnaSpec - Most Cited
AnaSpec, Eurogentec Group is pleased to offer anti-5-methylcytidine (Clone 33D3), Eurogentec’s most popular monoclonal antibody, for use in epigenetics research. 5-Methylcytidine is a modified base found in the DNA of plants and vertebrate. DNA methylation is a post-replication process... - December 11, 2010 - AnaSpec, EGT Group
AnaSpecs Offers Dyes for Labeling Amine- and Thiol-Modified Oligos
AnaSpec is pleased to highlight their own proprietary HiLyte Fluor dyes for labeling amine and thiol modified oligonucleotides from AnaSpec’s wide collection of amine and thiol reactive 6-isomeric dyes of fluoresceins and rhodamines. Fluorescent dye-labeled oligos are widely used as primers... - December 11, 2010 - AnaSpec, EGT Group
RayBiotech Renews Biomarker Discovery Grants for 2011
RayBiotech, Inc., announced today it will renew its Biomarker Discovery Pilot Grant program for 2011. RayBiotech will accept applications for pilot grants beginning in early 2011. Winning applicants will be eligible for restricted grants of $5,000 to $20,000 worth of RayBiotech products and/or services. This is the second year RayBiotech has sponsored these grants to demonstrate the application of antibody-based products to biomarker discovery. - December 04, 2010 - RayBiotech, Inc
GenScript Received OLAW (Office of Laboratory Animal Welfare) Approval for Animal Welfare Assurance
GenScript received the approval of Animal Welfare Assurance for its animal facility on 9 Nov, 2010. This approval accentuates the responsibilities and procedures of GenScript regarding the care and use of laboratory animals. - November 24, 2010 - GenScript USA Inc.
AnaSpec Introduces Anti-MOG (1-125), Mouse Monoclonal
Being the first in the industry to provide a whole suite of reagents and assay kits for the advancement of MS research, AnaSpec is pleased to announce the release of the mouse monoclonal Anti-MOG (1-125). Anti-MOG monoclonal antibody was produced by immunizing Balb/c mice with recombinant MOG... - November 14, 2010 - AnaSpec, EGT Group
AnaSpec Introduces Fluorescent Endothelin GO Peptides
AnaSpec is pleased to announce the release of new HiLyte Fluor™ 488 and 5-FAM labeled Endothelin peptides (human, bovine, porcine, rat) adding on its Endothelin peptides collection. Endothelins (ET) are highly potent vasoconstrictor proteins distributed throughout all areas of the body, and... - November 13, 2010 - AnaSpec, EGT Group
Immunologix Teams with GenScript to Produce Human Antibody Therapeutics Ready for Clinical Trials
Immunologix, Inc, a Charleston, SC biotechnology company and a leader in fully human therapeutic antibodies for a variety of diseases and GenScript, a contract research organization (CRO) based in Piscataway, NJ and the industry leader in bio-reagent services, assay development & screening,... - November 11, 2010 - GenScript USA Inc.
RayBiotech Launches Th17 Antibody Arrays for Immune Research
RayBiotech, Inc., the Protein Array Pioneer Company, today announced the release of several antibody array products that can detect up to 34 proteins related to the recently discovered Th17 lineage of immune cells. Th17 cells have been linked to the immune response to fungal and certain bacterial infections, as well being associated with several autoimmune diseases, including lupus, rheumatoid arthritis, Crohn's disease and multiple sclerosis. - November 03, 2010 - RayBiotech, Inc
RayBiotech Awarded NIH/STTR Grant for Endometriosis Research
RayBiotech, Inc., a leading developer and supplier of multiplex protein and antibody arrays, was recently awarded an STTR research grant to identify protein markers that could potentially be used in a diagnostic test for endometriosis. - October 22, 2010 - RayBiotech, Inc
AnaSpec Introduces SensoLyte® HAT (p300) & HAT (pCAF) Assay Kits
AnaSpec is pleased to announce the release of two HAT (histone acetyltransferase) fluorimetric kits adding in our growing list of epigenetics research products. The SensoLyte p300 Assay Kit provides a convenient assay for the screening of enzyme inhibitors and for continuous measurement of p300... - October 16, 2010 - AnaSpec, EGT Group
AnaSpec Introduces BAFF Protein
AnaSpec is pleased to announce the release of a recombinant human BAFF protein. Naïve B-cells, treated with 20-1000 ng/ml BAFF protein prepared by AnaSpec, has been showing increased IgG secretion compared to 2 leading commercial sources. BAFF (BlyS, TALL-1, THANK, TNFSF13B, zTNF4) belongs to... - October 07, 2010 - AnaSpec, EGT Group
RayBiotech and Gentel Partner to Offer Comprehensive Selection of Arrays on APiX Chromogenic Detection Platform
RayBiotech, Inc., a pioneer and leader in protein and antibody array technologies, and Gentel Biosciences, a leader in proteomics profiling tools, jointly announced today their partnership to develop and market RayBiotech's vast collection of easy-to-use antibody array products for use with Gentel's APiX™ chromogenic detection platform, a cost-effective alternative to laser fluoresecence scanners. - October 05, 2010 - RayBiotech, Inc
AnaSpec Introduces MESA BLUE qPCR Mixes for SYBR® Assay
AnaSpec has introduced Eurogentec’s MESA BLUE qPCR MasterMix Plus for SYBR® Assay. This MasterMix is a unique combination of our high-performance Hotstart MeteorTaq and an inert BLUE dye. The BLUE dye, which does not affect the qPCR reaction, considerably enhances the contrast between the... - September 30, 2010 - AnaSpec, EGT Group
OSO BioPharmaceuticals Appoints Susan Schniepp VP of Quality
OSO BioPharmaceuticals Manufacturing, LLC, has named Susan Schniepp as vice president of quality. In managing all operational quality-related issues, Schniepp is responsible for cGMP compliance of OsoBio’s facility. Quality-related matters concerning validation as well as regulatory affairs,... - September 30, 2010 - OSO BioPharmaceuticals Manufacturing, LLC
AnaSpec Introduces First FRET-Based Cathepsin B Assay
AnaSpec is pleased to announce the release of the SensoLyte® 520 Cathepsin B Activity Assay Kit, the industry’s first FRET-based kit for Cathepsin B. This homogeneous assay can be used for measuring Cathepsin B activity and for screening Cathepsin B inhibitors. The substrate employs in... - September 22, 2010 - AnaSpec, EGT Group
AnaSpec Introduces Histone GO® Peptides
AnaSpec, the world’s largest provider of on-demand GO® peptides has introduced a wide selection of Histone H1, H2A, H2B, H3 and H4 peptides, especially the H3 peptides. The rapidly expanding Histone H3 GO ® Peptides include sequences that are acetylated, mono-, di- or tri-methylated,... - September 16, 2010 - AnaSpec, EGT Group
AnaSpec Introduces the Release of Mant-ATP and Mant-GTP
AnaSpec is pleased to announce the release of Mant-ATP and Mant-GTP. - September 14, 2010 - AnaSpec, EGT Group
GenScript Launches CloneReadyTM Gene Collections
GenScript’s CloneReadyTM Gene Collections provide convenient and cost-effective solutions to researchers’ gene related practices. - September 09, 2010 - GenScript USA Inc.
AnaSpec Signs Distribution Agreement with Interprise Brasil
AnaSpec, Inc. and Interprise Brasil today announced a non-exclusive distributor agreement that will allow Interprise Brasil to distribute AnaSpec’s catalog and custom products throughout Brasil. - August 28, 2010 - AnaSpec, EGT Group
AnaSpec Visits with Noted Alzheimer’s Researcher, Dr. Patrick McGeer
AnaSpec’s general manager, Dr. Anita Hong and technical support specialist, Cecilia Po, visited the highly published and eminent Alzheimer’s researcher, Dr. Patrick McGeer and his associate, Dr. Jian-Ping Guo at the University of British Columbia, Vancouver, Canada on Aug. 12, 2010. - August 22, 2010 - AnaSpec, EGT Group
The Porcine microRNAome is Revealed
Results blaze a trail for advancement in pig biology as well the use of pigs as model organism for human biological and biomedical studies - August 20, 2010 - LC Sciences LLC
AnaSpec Introduces SensoLyte® Biotin Quantitation Assay Kit
AnaSpec is pleased to announce the release of the FRET based biotin quantitation kit. The SensoLyte® Biotin Quantitation Assay Kit provides a convenient way to estimate the efficiency of biotinylation for biotin-protein conjugates. The kit also can be used in quantitate biotin concentration in a solution. - August 20, 2010 - AnaSpec, EGT Group
AnaSpec Introduces Speedy 28-Day Antibody Service
AnaSpec introduces the Speedy 28-day custom polyclonal antibody service. Leveraging proven technology from Eurogentec, AnaSpec's parent company, this protocol uses a proprietary mixture of Freund's free immuno-stimulatory compounds. The first bleed, obtained at the accelerated rate of Day 21 after... - August 11, 2010 - AnaSpec, EGT Group
AnaSpec’s Published References Pass 1000
As compiled by Stanford University’s Highwire Press, the number of published papers that cite AnaSpec’s products has passed 1000. Products cited include AnaSpec’s custom and catalog peptides, antibodies, assay kits, dyes, standard amino acids, unusual amino acids and synthesis... - July 21, 2010 - AnaSpec, EGT Group
AnaSpec Introduces New SensoLyte® uPA & tPA Assay Kits
AnaSpec is pleased to introduce two plasminogen activator assay kits – the SensoLyte AFC Urokinase (uPA) Assay Kit and the SensoLyte AMC tPA Assay Kit. - June 19, 2010 - AnaSpec, EGT Group
AnaSpec Signs Distribution Agreement with Bioeasy Diagnostica
AnaSpec, Inc. and Bioeasy Diagnostica today announced a non-exclusive distributor agreement that will allow Bioeasy Diagnostica to distribute AnaSpec’s catalog and custom products throughout Brasil. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted, “AnaSpec... - June 18, 2010 - AnaSpec, EGT Group
WoundSeal - the Product That Stops Bleeding Instantly - Now Available in Canada
WoundSeal is a topical powder by Biolife that stops bleeding instantly. It has been licensed by Health Canada to introduce it to occupational health customers. Biolife has secured agreements with leading suppliers Zee Medical and SafeCross to serve Canadian market. - June 16, 2010 - Biolife
AnaSpec Introduces Rhodamine 110 Labeled GO® Peptides
Rhodamine 110 (Rh110)-labeled peptides are used in the study of a number of protease activity. - June 05, 2010 - AnaSpec, EGT Group